Nasopharyngeal carcinoma and Epstein-Barr virus. II. Clinical course and the anti-VCA antibody.
D000914:Antibodies, Viral / Q000032:analysis*; D005260:Female; D005455:Fluorescent Antibody Technique; D005500:Follow-Up Studies; D006258:Head and Neck Neoplasms; D004854:Herpesvirus 4, Human / Q000276:immunology*; D006801:Humans; D008297:Male; D009303:Nasopharyngeal Neoplasms / Q000175:diagnosis / Q000276:immunology* / Q000532:radiotherapy; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local; D011379:Prognosis; D012075:Remission, Spontaneous
D000914:Antibodies, Viral